ZYUS Life Sciences Corporation (TSXV:ZYUS)
0.7000
0.00 (0.00%)
At close: Dec 5, 2025
ZYUS Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 0.36 | 1.9 | 3.98 | 0.21 | 0.75 | 7.99 |
| Short-Term Investments | - | - | 1.87 | - | - | - |
| Cash & Short-Term Investments | 0.36 | 1.9 | 5.85 | 0.21 | 0.75 | 7.99 |
| Cash Growth | 4.33% | -67.50% | 2660.38% | -71.73% | -90.62% | - |
| Accounts Receivable | 0.39 | 0.05 | 0.16 | 0.2 | 0.02 | 0.01 |
| Other Receivables | - | 0.31 | 0.47 | 0.04 | 0.33 | 0.66 |
| Receivables | 0.39 | 0.37 | 0.63 | 0.24 | 0.35 | 0.68 |
| Inventory | 0.46 | 0.63 | 2.04 | 4.2 | 5.08 | 4.91 |
| Prepaid Expenses | 0.39 | 0.46 | 0.87 | 0.86 | 0.91 | 1.4 |
| Other Current Assets | - | - | - | 0.75 | 0.43 | 0.03 |
| Total Current Assets | 1.6 | 3.36 | 9.39 | 6.27 | 7.52 | 15.01 |
| Property, Plant & Equipment | 9.12 | 11.16 | 13.89 | 17.03 | 20.51 | 17.43 |
| Goodwill | - | - | 5.87 | 5.87 | 5.87 | 5.87 |
| Other Intangible Assets | - | - | 12.32 | 35.39 | 36.24 | 37.68 |
| Other Long-Term Assets | 0.14 | 0.15 | 0.15 | 0.16 | 0.16 | 0.15 |
| Total Assets | 10.85 | 14.67 | 41.63 | 64.71 | 70.29 | 76.14 |
| Accounts Payable | 8.67 | 4.48 | 3.44 | 8.51 | 5.68 | 3.8 |
| Accrued Expenses | - | 3.37 | 3.26 | 4.53 | 3.61 | 2.36 |
| Short-Term Debt | 1.84 | 0.08 | - | 0.9 | - | - |
| Current Portion of Long-Term Debt | 4.81 | 9.04 | 6.15 | 0 | - | - |
| Current Portion of Leases | 0.38 | 0.41 | 0.4 | 0.33 | 0.38 | 0.24 |
| Total Current Liabilities | 15.69 | 17.38 | 13.24 | 14.27 | 9.67 | 6.4 |
| Long-Term Debt | 6.08 | 0.37 | 0.64 | 30.8 | 22.05 | 10.98 |
| Long-Term Leases | 2.05 | 2.27 | 2.62 | 2.88 | 3.21 | 3.04 |
| Long-Term Deferred Tax Liabilities | - | - | 2.02 | 8.05 | 7.6 | 7.75 |
| Other Long-Term Liabilities | - | - | - | 3.98 | 2.59 | 3.96 |
| Total Liabilities | 23.82 | 20.02 | 18.51 | 59.97 | 45.1 | 32.12 |
| Common Stock | 158.82 | 156.7 | 154.09 | 92.67 | 78.05 | 72.74 |
| Additional Paid-In Capital | 10.79 | 9.21 | 5.39 | 5.63 | 19.97 | 19.36 |
| Retained Earnings | -186 | -173.99 | -140.19 | -97.6 | -72.94 | -49.48 |
| Comprehensive Income & Other | 3.42 | 2.74 | 3.82 | 4.04 | 0.11 | 1.4 |
| Shareholders' Equity | -12.97 | -5.34 | 23.11 | 4.74 | 25.19 | 44.02 |
| Total Liabilities & Equity | 10.85 | 14.67 | 41.63 | 64.71 | 70.29 | 76.14 |
| Total Debt | 15.15 | 12.16 | 9.81 | 34.9 | 25.64 | 14.26 |
| Net Cash (Debt) | -14.79 | -10.26 | -3.95 | -34.69 | -24.89 | -6.26 |
| Net Cash Per Share | -0.20 | -0.14 | -0.07 | -0.90 | -0.49 | -0.13 |
| Filing Date Shares Outstanding | 80.07 | 74.36 | 70.85 | 54.7 | 51.81 | 48.7 |
| Total Common Shares Outstanding | 78.15 | 74.36 | 70.85 | 54.7 | 51.81 | 48.7 |
| Working Capital | -14.09 | -14.02 | -3.86 | -8 | -2.15 | 8.6 |
| Book Value Per Share | -0.17 | -0.07 | 0.33 | 0.09 | 0.49 | 0.90 |
| Tangible Book Value | -12.97 | -5.34 | 4.92 | -36.52 | -16.92 | 0.47 |
| Tangible Book Value Per Share | -0.17 | -0.07 | 0.07 | -0.67 | -0.33 | 0.01 |
| Land | - | 0.88 | 0.88 | - | 0.88 | 0.88 |
| Machinery | - | 11.72 | 11.68 | 1.7 | 10.74 | 9.24 |
| Construction In Progress | - | - | - | 10.77 | 1.31 | 1.73 |
| Leasehold Improvements | - | 10.7 | 10.7 | 10.51 | 10.48 | 6.59 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.